Nov 27, 2013, 13:00 PM by Michael Croft

Bio-IT World | Ingenuity Systems is preparing for the release of a new platform for performing variant analysis in the clinic: a core component of the QIAGEN GeneReader pipeline. Yet like CLC bio, Ingenuity continues to tread an independent path under its new corporate owner.

Nov 27, 2013, 11:00 AM by Michael Croft

Bio-IT World News Brief | Rumors that the formal structure of the Institute for Genome Sciences and Policy at Duke University will shortly be dismantled have now been confirmed.

Nov 27, 2013, 08:55 AM by Michael Croft

Duke Check | The Duke Genome Institute may be in peril after a ten-year review, as insiders suggest the Institute will be dismantled and its members relegated to separate departments of the university.

Nov 26, 2013, 11:40 AM by Michael Croft

Bio-IT World | The Moore and Sloan Foundations are providing a $40 million grant to build university spaces for data science.

Nov 25, 2013, 10:50 AM by Michael Croft

Bio-IT World News Brief | Using the well-studied enzyme lysozyme as a proof-of-concept, researchers at Stanford's SLAC National Accelerator Laboratory have demonstrated that X-ray laser technology can generate 3D models of unknown proteins without any prior knowledge of their structure.

Nov 25, 2013, 10:00 AM by Michael Croft

Bio-IT World | The Food and Drug Administration issued a warning letter to 23andMe CEO Anne Wojcicki on Friday, demanding that the company "immediately discontinue marketing the [Personal Genome Service]."

Nov 25, 2013, 08:00 AM by Michael Croft

Bio-IT World News Brief | Oxford Nanopore this morning invited registration for the MinION Access Programme (MAP). Registration will remain open through the holiday period, the company said. In early 2014, at least two days notice will be given of closure of the registration period. Preference will not be given to early applicants.

Nov 22, 2013, 13:10 PM by Michael Croft

Bio-IT World | Twin brothers Obi and Malachi Griffith have developed a free online database, the Drug Gene Interaction Database at dgidb.org, where researchers can quickly sort through the known drug interactions in the human genome.

Nov 20, 2013, 12:00 PM by Michael Croft

Bio-IT World | CLC bio, the world’s largest software developer for first-tier analysis of raw sequencing data, was recently acquired by QIAGEN and swept into a sequencing-to-informatics pipeline built around the still-unreleased GeneReader instrument. Big changes for this industry leader? Perhaps not.

Nov 20, 2013, 08:00 AM by Michael Croft

Bio-IT World Roundup | Yesterday the FDA granted premarket clearance to Illumina's MiSeqDx platform as well as several diagnostic kits to go with the platform.

Nov 20, 2013, 08:00 AM by Michael Croft

BBC | Frederick Sanger, two-time winner of the Nobel Prize and considered the "father of genomics", has died at the age of 95.

Nov 19, 2013, 12:00 PM by Michael Croft

Technology Review | Children’s Mercy Hospital in Kansas City has joined the ranks of pediatric hospitals actively using genome sequencing in their NICUs.

Nov 19, 2013, 08:00 AM by Michael Croft

Computerworld | The Top 500 supercomputer list was released yesterday. Tianhe-2 in China still holds the top spot with Oak Ridge National Laboratories' Titan in the number 2 spot.

Nov 18, 2013, 14:00 PM by Michael Croft

Xconomy | Luke Timmerman calls this the "stingiest funding cycle for first-time biotech financings in almost two decades."

Nov 18, 2013, 11:00 AM by Michael Croft

Bio-IT World Roundup | Several new updates emerged from Amazon Web Services at the user conference last week including Kinesis and AppStream.

Nov 15, 2013, 13:00 PM by Michael Croft

Bloomberg | Alzheimer's Research UK will fund a new drug discovery institute for dementia research.

Nov 15, 2013, 00:25 AM by Michael Croft

Bio-IT World News Brief | A new polymerase, PrimPol, joins previous Sygnis patent QualiPhi as the company establishes its niche in DNA amplification scenarios that the most commonly used polymerases have difficulty processing.

Nov 14, 2013, 11:20 AM by Michael Croft

Wired | NuMedii has been hard at work finding alternative uses for existing drugs. Human trials have now commenced to use the antidepressant imipramine on small-cell lung cancer.

Nov 14, 2013, 11:05 AM by Michael Croft

Molecular Cell | Michael Laub's lab at MIT is examining a bacterium's own toxin-antitoxin systems for clues to the development of novel antibiotics.

Nov 14, 2013, 08:00 AM by Michael Croft

Computerworld | At the Amazon Web Services Reinvent conference, Andy Jassy spared nothing in his assessment of private clouds, saying they offer "none of the benefits" of public cloud offerings.